Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-001716-30Phase 2Completed
Phase 2, randomised, single-blind trial of Tyrosur in acne vulgaris and acne papulopustulosa (3 arms), sponsored by Clinical Research Center for Hair and Skin Science. Primary endpoint: Change in inflammatory lesion count. Started Aug 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-001716-30.